HC Wainwright Cuts Eledon Pharmaceuticals (NASDAQ:ELDN) Price Target to $13.00

Eledon Pharmaceuticals (NASDAQ:ELDN – Free Report) had its target price cut by HC Wainwright from $25.00 to $13.00 in a report issued on Tuesday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Eledon Pharmaceuticals’ FY2023 earnings at ($1.31) EPS. A number of other research firms […]

Related Keywords

Canada , ,Royal Bank ,Jmac Enterprises ,Nasdaq ,Hedge Funds Weigh In On Eledon Pharmaceuticals ,Renaissance Technologies ,Eledon Pharmaceuticals ,Eledon Pharmaceuticals Inc ,Cantor Fitzgerald ,Geode Capital Management ,News Ratings For Eledon Pharmaceuticals Daily ,Eledon Pharmaceuticals Stock Performance ,Free Report ,Eledon Pharmaceutical ,Get Free Report ,Capital Management ,Eledon Pharmaceuticals Daily ,Nasdaq Eldn ,Heldn ,Medical ,Lower Price Target ,Hc Wainwright ,